Global electrophysiology devices market is estimated to be valued at USD 9.70 Bn in 2024, exhibiting a CAGR of 12.8% during the forecast period (2024-2031). Electrophysiology refers to the study of physiological properties of electrical activity occurring in excitable tissues such as nerves, muscles, and the heart. Electrophysiology devices help in diagnosis and treatment of various heart rhythm disorders by facilitating procedures such as ablation and mapping of electrical signals in the heart. Factors such as rising geriatric population susceptible to arrhythmias, technological advancements, and growing preference for minimally invasive surgeries boosts demand for electrophysiology devices. However, high cost of sophisticated electrophysiology equipment can hamper its widespread adoption.

Market Dynamics:

Global electrophysiology devices market growth is driven by rising prevalence of cardiac arrhythmias, rising healthcare expenditure, growth of the medical device industry, and demand for minimally invasive procedures. According to WHO, cardiovascular diseases are the leading cause of deaths globally, with arrhythmias contributing significantly to mortalities. This has boosted the need for early detection and efficacious treatment of arrhythmias using electrophysiology devices. The continuous technological advancements have enhanced the capabilities of electrophysiology devices, enabling complex ablations and improved accuracy of diagnosis. However, high costs associated with electrophysiology equipment and procedures hamper the market growth. Furthermore, lack of skilled electrophysiologists poses a challenge for the market growth, particularly in developing regions. Ongoing research offers opportunities through developments such as catheter ablation for atrial fibrillation, remote magnetic navigation systems, and high-resolution 3D mapping systems.

Key Features of the Study:

• This report provides an in-depth analysis of the global electrophysiology devices market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global electrophysiology devices market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this includes Medtronic, VivaQuant, Inc., Johnson & Johnson Services, Inc., AliveCor, Inc., Bittium, Nihon Kohden Corporation, Shimmer, OMRON Healthcare, Co., Ltd., VivaLNK, Inc., Abbott, BIOTRONIK, Koninklijke Philips N.V., Omega Medical Imaging, LLC., HeartSciences, MicroPort Scientific Corporation, Siemens Healthcare GmbH.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global electrophysiology devices market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global electrophysiology devices market.

Detailed Segmentation-

• By Product Type:
  • Electrophysiology Monitoring Devices
    • Electrocardiograph
    • Holter Monitoring Devices
    • X-Ray Systems
    • Combo systems - Imaging and 3D mapping systems
    • Diagnostic Electrophysiology Catheters
  • Electrophysiology Treatment Devices
    • Implantable Cardioveter Defibrillators
    • Pacemakers
    • Cardiac Resynchronization Therapy Devices
    • Catheters
• By Indication:
  • Atrial Fibrillation
  • Atrioventricular Nodal Re-entry Tachycardia
  • Supraventricular Tachycardia
  • Bradycardia
  • Others (Wolff-Parkinson-White Syndrome, etc.)
• By End User:
  • Hospitals
  • Diagnostic Centers
  • Clinics
  • Others (Ambulatory Surgical Centers, etc.)
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa

Company Profiles:

• Medtronic
• VivaQuant, Inc.
• Johnson & Johnson Services, Inc.
• AliveCor, Inc.
• Bittium
• Nihon Kohden Corporation
• Shimmer
• OMRON Healthcare, Co., Ltd.
• VivaLNK, Inc.
• Abbott
• BIOTRONIK
• Koninklijke Philips N.V.
• Omega Medical Imaging, LLC.
• HeartSciences
• MicroPort Scientific Corporation
• Siemens Healthcare GmbH